An Investigation of the Safety of 4 Different Doses of Autologous Muscle Derived Cells as Therapy for Stress Urinary Incontinence

Completed · Phase 2

Conditions studied: Stress Urinary Incontinence, Cell Therapy

In brief

This is a clinical investigation approved by US FDA and Canadian Health Authority to study the safety and potential effectiveness of the autologous muscle cells for the treatment of stress urinary incontinence.

Key facts

Study ID
NCT00847535
Run by
Cook MyoSite
People needed
66
Starts
2008-10-09
Expected to finish
2011-11-02
Last updated by the study team
2023-09-08

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.